Time-varying risks of second events following a DCIS diagnosis in the population-based Vermont DCIS cohort.

导出 OA

翻译打印收藏纠错

作者： Brian L,Sprague ^[1] ; Pamela M,Vacek ^[2] ; Sally D,Herschorn ^[3] ; Ted A,James ^[4] ; Berta M,Geller ^[5] ; Amy,Trentham-Dietz ^[6] ; Janet L,Stein ^[4] ; Donald L,Weaver ^[7]

作者单位： Department of Surgery, University of Vermont, 1 S. Prospect St, UHC Room 4425, Burlington, VT, 05401, USA. brian.sprague@uvm.edu. ^[1] Department of Radiology, University of Vermont, Burlington, VT, USA. brian.sprague@uvm.edu. ^[2] University of Vermont Cancer Center, University of Vermont, Burlington, VT, USA. brian.sprague@uvm.edu. ^[3] University of Vermont Cancer Center, University of Vermont, Burlington, VT, USA. ^[4] Medical Biostatistics Unit, University of Vermont, Burlington, VT, USA. ^[5] Department of Radiology, University of Vermont, Burlington, VT, USA. ^[6] Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA. ^[7] Department of Family Medicine, University of Vermont, Burlington, VT, USA. ^[8] Department of Population Health Sciences, School of Medicine and Public Health, University of Wisconsin Carbone Cancer Center, University of Wisconsin-Madison, Madison, WI, USA. ^[9] Department of Biochemistry, University of Vermont, Burlington, VT, USA. ^[10] Department of Pathology, University of Vermont, Burlington, VT, USA. ^[11]

关键词 Breast cancer Cohort studies Disease-free survival Ductal carcinoma in situ Treatment outcome